Saturday, July 11, 2026

Intelligence · Clinical pipeline

Phase II Pipeline Programs

Proof-of-concept and dose-finding clinical programs in Phase II development.

Programs 7,238
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.

Top sponsors

Pipeline programs

Page 64 of 151
  1. HTX-011B

    Heron Therapeutics

    Postoperative Pain

    phase 2 small molecule completed

    1 trial
  2. HTX-034

    Heron Therapeutics

    Bunions

    phase 2 small molecule completed

    1 trial
  3. HUMSCs combined with bovine type I collagen

    The First People's Hospital of Lianyungang

    Burn Wounds

    phase 2 other active

    1 trial
  4. HZNP-DAX-202

    Elan Pharma International

    Primary Discoid Lupus Erythematosus

    phase 2 small molecule active

    1 trial
  5. HZNP-HZN-1116-201

    Elan Pharma International

    Sjögren’s Syndrome

    phase 2 small molecule active

    1 trial
  6. HZNP-HZN-825-301

    Elan Pharma International

    Diffuse Cutaneous Systemic Sclerosis

    phase 2 small molecule active

    1 trial
  7. HZNP-HZN-825-303

    Elan Pharma International

    Idiopathic Pulmonary Fibrosis

    phase 2 small molecule active

    1 trial
  8. Halneuron

    Dogwood Therapeutics

    Chemotherapy Induced Neuropathic Pain

    phase 2 small molecule active

    1 trial
  9. HarMono-T 5 microlitres/mL gas and solvent for dispersion for injection/infusion

    Lacuna Pharma Pty Ltd

    Ultrasound contrast agent, for diagnostic purposes (to assess indeterminate kidney lesions)

    phase 2 small molecule active

    1 trial
  10. Heart Rate Variability Biofeedback

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Smoking

    phase 2 mab completed

    1 trial
  11. Heparin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Thromboprophylaxis

    phase 2 small molecule active

    1 trial
  12. Heparin and Rivaroxaban

    The First People's Hospital of Lianyungang

    Liver Cirrhosis

    phase 2 small molecule completed

    1 trial
  13. Hepatitis A Vaccine

    Takeda

    Healthy Volunteers

    phase 2 mab completed

    1 trial
  14. Herbal Medicine C-117

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Occlusion and Stenosis of Unspecified Cerebral Artery

    phase 2 small molecule active

    1 trial
  15. Heroin Dependence

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    phase 2 small molecule terminated

    1 trial
  16. Herombopag

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non Severe Aplastic Anemia

    phase 2 small molecule completed

    1 trial
  17. Herombopag

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chemotherapy-induced Thrombocytopenia

    phase 2 small molecule active

    1 trial
  18. Herzuma

    Vera Therapeutics

    HER2 Enriched Subtype Breast Cancer, Herzuma, PAM50 Study

    phase 2 small molecule active

    1 trial
  19. HiPSC-RPE cells

    The First People's Hospital of Lianyungang

    AMD - Age-Related Macular Degeneration

    phase 2 mab active

    1 trial
  20. High Dose SAB-142

    SAB Biotherapeutics

    Type 1 Diabetes

    phase 2 small molecule active

    1 trial
  21. High-Low Dose Radiotherapy

    Jian Li

    Nasopharyngeal Carcinoma (NPC)

    phase 2 other active

    1 trial
  22. High-dose donepezil

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Use Disorders

    phase 2 small molecule completed

    1 trial
  23. Homoharringtonine

    Teva Pharma GmbH

    Myeloid Leukemia, Chronic

    phase 2 small molecule terminated

    1 trial
  24. Humalog

    HALOZYME THERAPEUTICS, INC.

    Type 1 Diabetes Mellitus

    phase 2 small molecule completed

    1 trial
  25. Humalog

    HALOZYME THERAPEUTICS, INC.

    Diabetes Mellitus, Type 2

    phase 2 small molecule completed

    1 trial
  26. Human Adipose-Derived Stem Cell Exosomes

    The First People's Hospital of Lianyungang

    Acute Ischemic Stroke

    phase 2 mab active

    1 trial
  27. Human COVID-19 immunoglobulin (pH4) for intravenous injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    phase 2 mab active

    1 trial
  28. Human Mesenchymal Stromal Cells

    United Therapeutics Europe Ltd

    Respiratory Distress Syndrome, Adult

    phase 2 mab completed

    1 trial
  29. Human Umbilical Cord derived MSCs

    CytoMed Therapeutics Ltd

    Lupus Nephritis

    phase 2 mab active

    1 trial
  30. Humanized CD7 CAR-T cells

    The First People's Hospital of Lianyungang

    T Lymphoblastic Leukemia/Lymphoma

    phase 2 mab active

    1 trial
  31. Humanized anti-CD117 Monoclonal Antibody (JSP191)

    Jasper Therapeutics

    SCID

    phase 2 mab terminated

    1 trial
  32. Humira 40 mg solution for injection in pre-filled syringe

    Disc Medicine

    Inflammatory Bowel Disease (IBD)

    phase 2 small molecule active

    1 trial
  33. Huzhang granule

    Universal Integrated

    Gouty Arthritis

    phase 2 small molecule active

    1 trial
  34. Hyaluronidase

    Amphastar France Pharmaceuticals

    Allergic Skin Reaction

    phase 2 small molecule completed

    1 trial
  35. Hydrocortisone Modified Release Capsules

    NEUROCRINE BIOSCIENCES INC

    Endocrine Disease

    phase 2 small molecule completed

    1 trial
  36. Hydrocortisone acetate and lidocaine hydrochloride

    CITIUS ONCOLOGY, INC.

    Hemorrhoids

    phase 2 small molecule completed

    1 trial
  37. Hydrogel of spirulina-derived exosomes.

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Radiation-induced Esophagitis

    phase 2 small molecule active

    1 trial
  38. Hydrogen Peroxide

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 2 small molecule active

    1 trial
  39. Hydroxycarbamid

    BRIGHT MINDS BIOSCIENCES INC.

    Central Retinal Vein Occlusion, Non-Ischemic

    phase 2 small molecule active

    1 trial
  40. Hydroxychloroquine (HCQ)

    Teva Pharma GmbH

    COVID-19

    phase 2 small molecule terminated

    1 trial
  41. Hydroxyproline and Leucine

    Ultragenyx UK Limited

    Hyperoxaluria

    phase 2 small molecule completed

    1 trial
  42. Hydroxypropyl Guar Galactomannan

    Alcon Laboratories (Australia) Pty Ltd

    Dry Eye Disease

    phase 2 small molecule completed

    1 trial
  43. Hydroxyurea

    Sana Biotechnology

    Thalassemia, Beta

    phase 2 small molecule active

    1 trial
  44. Hyperbaric Oxygen Therapy

    Summit Therapeutics

    TBI Traumatic Brain Injury

    phase 2 small molecule active

    1 trial
  45. Hyperbolic

    Talion

    non-small cell lung cancer (NSCLC)

    phase 2 small molecule active

    1 trial
  46. Hyperimmune plasma

    Lxo Ireland Designated Activity Company

    SARS-CoV 2

    phase 2 mab completed

    1 trial
  47. Hyperpolarized 129Xenon gas

    United Therapeutics Europe Ltd

    Pulmonary Vascular Disease

    phase 2 small molecule completed

    1 trial
  48. Hyperpolarized 13C-Pyruvate injection

    Hospital Authority, Hong Kong

    Gynecologic Cancer

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many Phase II pipeline programs are in the directory?

7,238 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.